Carbyne-backed SuanNutra agrees to buy IFF ingredients portfolio

SuanNutra, backed by Carbyne Equity Partners, has agreed to acquire a portfolio of specialty natural ingredients businesses from IFF, PE Hub reported. The transaction would combine botanical extraction and fermentation operations into a group employing around 700 people and serving more than 1,200 customers in over 60 countries, according to PE Hub.

IFF is a New York-listed flavors and fragrances company. The businesses being sold are described by PE Hub as specialty natural ingredients operations, although the report did not give a purchase price or identify individual legal entities included in the deal.

The enlarged manufacturing base is expected to include botanical extraction capacity in Spain, Slovenia and Peru, as well as fermentation operations in the United States, PE Hub reported. That footprint would give SuanNutra production assets across Europe, Latin America and North America.

Cross-border assets and customer reach

The reported deal would broaden SuanNutra’s scale in ingredients production by adding facilities that use two different production routes. Botanical extraction generally involves processing plant material to isolate ingredients for commercial use, while fermentation uses controlled biological processes to produce target compounds. The PE Hub report identified both capabilities as part of the combined manufacturing platform.

The customer base cited by PE Hub, more than 1,200 customers across more than 60 countries, points to an international sales mix for the enlarged group. The report did not provide a breakdown by region, end market or product line.

For Carbyne Equity Partners, the transaction would expand a portfolio company through an acquisition from a publicly listed strategic seller. Such carve-out transactions can move selected assets from a larger corporate group into a more focused platform, though PE Hub did not describe the strategic rationale for IFF or SuanNutra beyond the agreed sale.

Closing timetable

The acquisition is expected to close by the end of 2026, subject to regulatory approvals and customary closing conditions, PE Hub reported. Until those conditions are met, ownership of the businesses remains subject to completion of the agreed process.

Regulatory clearances in deals of this type typically determine whether competition authorities or other relevant agencies permit a transfer of control. Customary closing conditions can include procedural, contractual or operational requirements set out in the purchase agreement. PE Hub did not specify which jurisdictions must approve the transaction.

The reported timetable leaves a lengthy period before completion, which may reflect the cross-border nature of the assets and the need for approvals. PE Hub did not report any expected changes to employment levels, management or the operating footprint beyond the combined figures and locations cited for the enlarged group.

This story draws on original reporting from PE Hub.